|
⚲
|
| Keyboard |
| KDev Investments AB
✚
|
|
|---|---|
| CIK # | 0001789888 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001789888] | |
| 4 | [0001789888] | |
| SC 13G | [0001789888] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| KDEV Investments AB | Aprea Therapeutics Inc | [2020-02-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Karolinska Development AB | |
| Aprea Therapeutics Inc | |
| KDev Investments AB | |
| KCIF Co-Investment Fund KB |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aprea Therapeutics Inc APRE
Common Stock
|
2020-07-07 | Sell | 241,703 | $34.55 | 8,350,839 |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2020-04-13 | Sell | 210,548 | $31.25 | 6,579,625 |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2019-10-07 | Conversion | 1,600,559 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Series C Convertible Preferred Stock · derivative
|
2019-10-07 | Conversion | 430,467 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Series B Convertible Preferred Stock · derivative
|
2019-10-07 | Conversion | 590,445 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Series A Convertible Preferred Stock · derivative
|
2019-10-07 | Conversion | 579,647 | $0.00 |